SUVIZUMAB
UNII 4AJ2TI6DPI

Substance Identification & Data

This profile provides standardized clinical and technical data for Suvizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4AJ2TI6DPI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 914257-21-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4AJ2TI6DPI
CAS Registry Number
914257-21-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SUVIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C152483
National Cancer Institute reference terminology for clinical and research data.
INN ID
9185
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suvizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUVIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) ENVELOPE GLYCOPROTEIN GP120 THIRD VARIABLE LOOP V3), HUMANIZED MONOCLONAL ANTIBODY
SUVIZUMAB [INN]
SUVIZUMAB [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus